2-chloro-N-methyl-3-oxobutanamide | CAS:4116-10-3

We serve 2-chloro-N-methyl-3-oxobutanamide CAS:4116-10-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-chloro-N-methyl-3-oxobutanamide

Chemical Name:2-chloro-N-methyl-3-oxobutanamide
CAS.NO:4116-10-3
Synonyms:2-chloro-N-methyl-3-oxobutanamide
Butanamide,2-chloro-N-methyl-3-oxo
2-Chloro-N-methyl-3-oxobutyramide
2-chloro-N-methyl-3-oxobutaneamide
Acetoacetamide,2-chloro-N-ethyl
 
Physical and Chemical Properties:
Density 1.188g/cm3
Boiling Point 284.1ºC at 760mmHg
Melting Point 78-80ºC
Molecular Formula C5H8ClNO2
Molecular Weight 149.57600
Flash Point 125.6ºC
Index of Refraction 1.447
 
Specification:
Appearance:White crystal
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Monocrotophos(CAS:6923-22-4).



Contact us for information like 2-chloro-N-methyl-3-oxobutanamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Acetoacetamide,2-chloro-N-ethyl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Acetoacetamide,2-chloro-N-ethyl Use and application,2-chloro-N-methyl-3-oxobutanamide technical grade,usp/ep/jp grade.


Related News: The chemical compound which is in the process of becoming an API from a raw material is called an intermediate.4-METHYL-2-NITROPHENYL ISOTHIOCYANATE manufacturer The chemical compound which is in the process of becoming an API from a raw material is called an intermediate.N-[(2R,3S)-2-(2,5-Difluorophenyl)tetrahydro-5-oxo-2H-pyran-3-yl]carbamic acid 1,1-dimethylethyl ester supplier All of China’s provinces and territories have now been touched by the outbreak.N-Propylsulfuric diamide-sodium vendor South Korea said on Sunday that it would deny entry to any foreigners who have traveled to Wuhan and surrounding Hubei Province in China in the past 14 days.At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth.